Cambridge Biomedical Campus, Addenbrooke’s site
The scheme, being delivered for Cambridge Medipark Limited, will consist of a three-storey laboratory building and a four-storey office building, connected by an atrium link. Once complete, the scheme will provide around 100,000sq ft of office and laboratory space, and will be occupied by Abcam, a global leader in the supply of life science research tools.
Abcam is a global life sciences company providing highly validated antibodies and other binders and assays to the research and clinical communities to help advance the understanding of biology and causes of disease.
Works are due to bega in March 2017 with a scheduled completion date of late 2018.
The new site will allow Abcam to combine its three current facilities in Cambridge into one new state-of-the-art global headquarters.